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Although Bence Jones proteins have been recog-
nized for well over 100 years, it was not until 1962
that Edelman and Gaily [1] demonstrated these pro-
teins to be in fact the light polypeptide chains of all
immunoglobulin classes. Strictly speaking, the term
Bence Jones protein" is reserved for those pro-
teins identified by their solubility properties on
heating [2]. These properties, however, have been
shown to be somewhat nonspecific [3], and the term
is now commonly used to denote appreciable
amounts of, usually monoclonal, light chain appear-
ing in the urine or serum of patients with multiple
myeloma, primary amyloidosis [4], and monoclonal
gammopathies [5]. Such light chains of mol wt of
approximately 22,000 daltons commonly exist in di-
mer form in aqueous solution [1]. Bence Jones pro-
teinuria is reported in various studies as being pres-
ent in 40 to 80% of patients with myeloma [6, 7] and
as being almost invariably present in 25% of pa-
tients with light-chain myeloma, in over 90% of pa-
tients with rarely occurring IgD-myeloma, in 35%
of patients with IgG-myeloma, and 20% of those
with IgA-myeloma [7].
Immunoglobulin light chains are normally filtered
at the glomerulus and then catabolized in renal
tubular epithelium [8-il]. Experiments both in man
and mice with normal renal function have shown
that when small doses of labeled light chain are in-
jected, 1% or less is excreted in the urine [10, 11].
Waldmann et al [11] have estimated that 5 mg/kg/day
of A light chain is filtered in the normal human, with
0.04 mg/kg/day being excreted in the urine. Immuno-
histologic studies have shown that the vast majority
of light chain is reabsorbed by proximal tubular epi-
thelium [12]. Therefore, under normal circum-
stances, only minute amounts of light chain are pre-
sented to the distal nephron. In conditions such as
multiple myeloma, macroglobulinemia, monoclonal
gammopathy, and amyloidosis, very large amounts
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of light chain or Bence Jones protein may appear in
the urine. It would seem that, in such situations, the
capacity of the tubular epithelium to reabsorb and
catabolize light chain is exceeded. Quantitative data
on the capacity of proximal tubules to reabsorb light
chain when the filtered load is large are lacking,
though previous experiments from our laboratory
have shown that about 20% of a dose of 300 mg K
chain injected i.p. in the rat was excreted in the
urine over the first 24 hours and none subsequently
[12].
There is now considerable clinical and experi-
mental evidence to suggest that Bence Jones pro-
teins, or at least some, are nephrotoxic. Cauchie et
al [13] described a highly significant relationship be-
tween the presence of Bence Jones proteinuria and
uremia, and there appears to be an unusually high
incidence of Bence Jones proteinuria in patients
with myeloma who develop episodes of acute renal
failure. In a recent series and review of the litera-
ture by DeFronzo et al [14], 19 of 27 patients with
myeloma and acute renal failure had Bence Jones
proteinuria. The same group of investigators have
also described greater impairment of creatinine
clearance, PAH clearance, and urinary con-
centrating and acidifying ability in myeloma pa-
tients with Bence Jones proteinuria compared to
those without [15]. A number of patients, however,
continue to pass large amounts of Bence Jones pro-
tein in the urine for years with little or no impair-
ment of renal function, suggesting that certain
Bence Jones proteins may be more nephrotoxic
than others.
Koss, Pirani, and Osserman [16] have shown that
intraperitoneal injection of large amounts of one A
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Bence Jones protein into mice produced a cast ne-
phropathy with increase in serum urea nitrogen,
though two other proteins tested under the same
conditions failed to produce this effect. Previous
studies from our laboratory failed to show any
change in renal function apart from a rise in protein
and albumin excretion in rats injected i.p. with 300
mg of one K light chain, obtained from a patient who
eventually died with moderate renal impairment. In
vitro studies by Preuss, Hammack, and Murdaugh
[17] suggest that Bence Jones proteins may inhibit
proximal tubular organic anion transport and gluco-
neogenesis, though the purity of the preparations
used here has been questioned [18].
To test the hypothesis that physical and chemical
properties of certain individual Bence Jones pro-
teins may be important in determining nephrotoxici-
ty, we isolated and characterized Bence Jones pro-
teins from 11 patients with myeloma and various de-
grees of renal dysfunction and tested them for acute
nephrotoxicity in the aciduric, hydropenic rat.
Methods
Characterization of urinary proteins. Twenty-
four-hour urine samples were collected from 11 pa-
tients with myeloma, Bence Jones proteinuria, and
varying degrees of renal dysfunction. Urine was
collected in ice with thymol added as a pre-
servative. After removal of Tamm Horsfall muco-
protein, urine samples were concentrated with use
of Amicon UM-lO membranes, dialyzed against dis-
tilled water, and analyzed by cellulose acetate elec-
trophoresis [19] and immunoelectrophoresis [20] us-
ing antisera to whole human serum, K and A light
chain, and Fc fragment. Six proteins were charac-
terized as A; and 5, as K. The proteins were charac-
further isolated by Sephadex G-75 gel filtration [21],
and monomer and dimer fractions were collected.
Both fractions were present in all but 4 patients, in
whom only dimer was present.
Isoelectric focusing [22] was used to determine
the isoelectric point (p1) of individual dimer frac-
tions. A vertical pH gradient was set up and main-
tained in a density gradient made from a sucrose
solution. The apparatus used was a LKB-8l01
(LKB Produkter A.B., Stockholm Bronma, Swe-
den), and the 2 pH ranges used as Ampholine car-
rier electrolytes were 3 to 10 and 4 to 7. The protein
content in the fractions isolated was measured by
absorbancy at 280 nm. Pooled fractions were sub-
mitted to further characterization by immuno-
diffusion [23] and immunoelectrophoresis.
Protein secondary structure was examined by cir-
cular dichroism. Circular dichroism (CD) spectra
were obtained with a Cary 61-CD spectopolarimeter
and a 1-mm path length cuvette while flushing the
optical path with nitrogen. The CD instrument was
calibrated with an aqueous solution of d- 10-cam-
phorsulfonic acid (Aldrich) [241. The proteins were
studied at a concentration of 50 mg/ml in 20 mM po-
tassium phosphate buffer (pH, 7.0). The analysis of
spectra used here was novel for Bence Jones pro-
teins in as far as the curve fitting was done using the
STEPIT subroutine [25] in a Fortran program, HE-
LIX, which describes the data within 95% con-
fidence limits as estimated by the chi square good-
ness of fit criterion. This algorithm describes the
CD spectrum using a three-component model con-
sisting of fraction a helix, fraction /3-pleated sheet,
and a third category consisting of a total of all re-
maining secondary structure types. The standard el-
lipticity values are based on CD spectra obtained on
proteins with known X-ray crystallographic struc-
ture [26].
In vivo studies. Female Sprague Dawley rats
weighing 150 to 200 g were kept in metabolic cages
with food withdrawn and with 1% ammonium chlo-
ride added to the drinking water for 24 hours prior
to injection. Immediately prior to injection, rats
were bled via the tail vein, and the bladder was
emptied by manual compression. Urinary pH was
determined on freshly voided urine. All rats with
urine pH of 5.5 or less were then injected i.p. with
300 mg of test protein in 1 cc of normal saline. All
protein solutions were urea-free and were clarified
by centrifugation and passed through a no. 13 Milli-
pore filter prior to injection. Groups of 3 rats were
injected with Bence Jones protein dimer from each
of the 11 patients. Sixteen rats were injected with
equine myoglobin (p1, 6.8), 9 with ovalbumin (p1,
3.4), and 9 with bovine serum albumin. Rats were
then kept in metabolic cages for 6 hours, with any
urine passed being collected under mineral oil.
Then, the bladder again was emptied. Rats then
were sacrificed under sodium pentobarbital anes-
thesia, with renal tissue samples taken for ultra-
structural and immunohistologic studies and with
blood samples obtained by cardiac puncture. Blood
samples were analyzed for serum urea nitrogen (ki-
netic urease method with IL 919 autoanalyzer) and
creatinine (kinetic alkaline picrate method with IL
919 autoanalyzer) concentrations, and urine sam-
ples were analyzed for osmolality (freezing-point
depression). Light chain content was determined by
radial immunodiffusion.
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Table 1. Clinical features and protein type in 11 patients with
Bence Jones proteinuria
Patient
no. Diseasea
Impaired
renal
functionb
Acute
renal
fai1ure
Cast
nephropathy
1 IgAKmyeloma ++ 0 ND
2 LC K myeloma 0 0 ND
3 IG K myeloma + 0 0
4 IgD A myeloma + + + 0 + + +
5 IgA K myeloina 0 0 ND
6 LC A myeloma + + + XI +
7 LC A myeloma + + + XI +
8 IgA A myeloma + + + 0 ND
9 IgG A myeloma + + ÷ 0 ND
10 IgA K myeloma + + + 0 + + +
11 LCxmyeloma +++ 0 +++
a LC is light chain.
b Renal function is scored on lowest creatinine clearance dur-
ing followup period. 0 = >80 mllmin, + = 50to 80 mllmin, ++ =
20 to 50 mi/mm, and +++ = <20 mI/mm.
Xl = I episode.
To further investigate the effect of urine pH on
nephrotoxicity, 7 rats were fed 6% sodium bicar-
bonate in the drinking water for 24 hours and then
gavage fed I cc of 6% sodium bicarbonate 2 hours
prior to injection so that the urine pH would be
above 8. These rats were then injected i.p. with 300
mg of Bence Jones protein dimer, A-type (p1, 6.2),
from patient 9. Changes in renal function over 6
hours were compared with 7 aciduric rats injected
with the same protein preparation.
Tissue for immunohistology was processed by
the thin-section technique of Post [27], and sections
incubated with fluorescein-conjugated rabbit or
goat antisera to human K and A chain, Fc fragment,
and rat albumin were examined with a Leitz Ortho-
lux fluorescence microscope with appropriate filtra-
tion. Tissue for electron microscopy was processed
as described previously [12], and ultrathin sec-
tions were examined with a Phillips 300 electron mi-
croscope.
Results
Protein characterization. The clinical details of
the 11 patients from whom the urinary protein was
isolated are shown in Table 1. Three patients (2, 3,
and 5) had relatively normal renal function during
their clinical course. Two patients (6 and 7) had epi-
sodes of acute renal failure following intravenous
urography. In neither case was there recovery of
renal function, and renal biopsy specimens obtained
in both cases within 24 hours of the onset of oliguria
revealed only minor distal cast formation. Three pa-
tients (4, 10, and 11) with chronically impaired renal
function showed the characteristic cast nephropa-
thy of myeloma kidney.
The protein characteristics are shown in Table 2.
Five Bence Jones proteins were type K, and six
were type A. In general, both monomer and dimer
fractions were isolated by Sephadex G-75 chroma-
tography except for one K and three A proteins
where a dimer peak only was present. Protein isoe-
lectric point ranged from 5.2 to 6.6. In general, pa-
tients with better renal function had Bence Jones
protein of lower p1. Most proteins of higher p1 asso-
ciated with impaired renal function were type A.
The circular dichroism studies showed that, in gen-
eral, K light chains were of lower a helix content
than were A proteins, as has been shown by others.
One K protein (CD), however, had an extremely
high a helix content. There did not seem to be a
relationship between clinical renal impairment and
protein secondary structure.
In vivo studies. Changes in serum urea nitrogen
concentration in the 33 rats injected with the 11
Bence Jones protein dimer preparations of various
Table 2. Summary of protein characterization studies from 10 patients with Bence Jones proteinuria
.Patient
no. Light chain type Monomer/dimer p1
Internal structurea, %
a helix /3-sheet Remainder
I K5 M, D 5.3 9.5 0.5 24.5 0.6 66.0
2 K' M, D 5.2 9.6 0.4 28.5 1.9 62.0
3 K D 5.4 59.9 0.6 12.0 2.1 28.1
4 A D 5.6 15.2 0.6 23.1 2.9 61.7
5 K M, D 5.8 13.8 0.7 18.9 4.3 67.3
6 A M, D 5.8 18.6 0.5 20.9 1.7 60.5
7 A D 6.2 15.5 0.5 21.7 0.6 62.8
8 A D 6.2 14.0 0.2 30.8 0.6 55.2
10 K M, D 6.6 13.2 1.0 34.2 2.1 52.6
11 A M, D 6.6 20.4 2.2 24.0 3.8 55.6
a Values are means I so.
b Group 1
Ip1 are shown in Fig. 1. There was a highly signifi-
cant correlation (P < 0.005) between increase in
serum urea nitrogen concentration over the 6-hour
experimental period and the protein p1. Table 3
shows mean increase in urea nitrogen and serum
creatinine concentrations in rats injected with
Bence Jones protein (BJP) of p1 less than 5.7, those
of p1 greater than 5.7, myoglobin, ovalbumin, and
bovine serum albumin (BSA). Rats injected with six
Bence Jones protein dimer preparations of p1 great-
er than 5.7 had a mean rise in serum urea nitrogen of
28.0 mg/dl and in serum creatinine of 0.71 mg/dl,
compared to rises of 5.3 mg/dl and 0.06 mg/dl, re-
spectively, in rats injected with seven dimer prepa-
rations of p1 greater than 5.7. Differences in values
for change in serum urea nitrogen and creatinine
when comparing these two groups were significant
at the 1% level when analyzed by the Mann
Whitney U test [281. There was no significant dif-
ference between changes in serum creatinine and
urea nitrogen when comparing rats injected with
Bence Jones dimer of p1 less than 5.7, myoglobin,
ovalbumin, or bovine serum albumin.
Figure 2 shows light chain excretion rates over
the 6-hour experimental period for 29 rats injected
with the 11 Bence Jones protein dimer preparations
compared to change in serum urea nitrogen. There
was a wide variation in excretion rate, ranging from
2 g/min to 200 g/min, and a significant negative
correlation (P < 0.001) between protein excretion
rate and rise in urea nitrogen. In general, excretion
rates of proteins of higher isoelectric point were
less, but this phenomenon could not be separated
from the greater rise in serum urea nitrogen in rats
injected with these proteins. The mean excretion
rate in 14 experiments where the injected protein
was type K was 23.9 (sEM) 1.46 p.g/min, compared
with a mean of 13.6 (sEM) 1.25 tg/min, in 15 ex-
periments where type A protein was injected. These
values were not significantly different on analysis
by the unpaired Student's t-test.
The 7 alkaluric rats (urine pH > 8) injected with
type-A Bence Jones protein dimer of p1 6.2 from pa-
tient 9 showed a mean rise of 1.8 mg/dl in serum
urea nitrogen and 0.01 mg/dl in serum creatinine
concentration over 6 hours, compared with a mean
Table 3. Mean rise in serum urea nitrogen (ZSUN) and creatinine
(iCreatinine) concentration over 6 hours for rats injected i.p.
with 300mg of test proteina
Group
Protein
injected p1
SUN'
mgldl
Creatinineb
mgldl
I BJPdimer <5.7 5.3(N 12)
(—9to +12)
0.06(N = 10)
(—0. 19 to +0.41)
2 BJPdimer >5.7 28.0 (N = 21)
(+6to+56)
0.71c (N = 18)
(+0.OSto+1.78)
3 Myoglobin 6.8 52d (N = 16)
(—4to +12)
0.07 (N = 16)
(—0.I8to +0.39)
4 Ovalbumin 43 2d (N = 9)
(—8to+7)
009d (N = 9)
(—0.l5to+0.40)
5 BSA 4•9 00d (N 9)
(—lOto+7)
Abbreviations used are: BJP, Bence Jones protein; BSA, bo-
vine serum albumin; p1, isoelectric point; N, number of observa-
tions.
b Range is given in parentheses.
P < 0.01 compared to group 1.
d NS, compared to group 1.
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Fig. 1. Change in serum urea nitrogen concentration (ZBUN) over 6 hours following i.p. injection of 300mg of 11 different Bence Jones
protein dimer preparations of p1 5.2 to 6.6 intO 33 aciduric, hydropenic rats.
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rise of 19.3 mg/dl in urea nitrogen and 0.55 mg/dl in
creatinine in 7 aciduric rats (urine pH < 5.5) injected
with the same protein preparation (Table 4). Dif-
ferences between these two groups were significant
at the same level (P = 0.009) for both urea nitrogen
and creatinine when analyzed by the Mann Whitney
U test. Preinjection urine osmolality ranged from
1500 to 2200 mOsm in the aciduric group and 1800
to 2300 mOsm in the alkaluric group.
The morphologic studies, which will be reported
in detail separately, showed proximal tubular drop-
lets immunoreactive with the injected light chain
type in all rats injected with Bence Jones protein.
Electron-dense casts were seen in the distal con-
voluted tubule, cortical collecting tubule, and med-
ullary collecting duct in 9 aciduric rats with acute
deterioration of renal function. These casts were
immunoreactive with antisera to the injected light
chain type, but with less than 30% of medullary col-
lecting ducts being involved on renal cross-section.
No casts were seen in rats injected with Bence
Jones protein preparations of p1 < 6.2, in alkaluric
Table 4. Comparison of changes in serum urea nitrogen (LSUN)
and serum creatinine (Acreatinine) concentrations over 6 hours
for aciduric and alkalunc rats injected with 300 mg Bence Jones
protein dimer (p1, 6.2) from patient 9
Urine pH N
SUNa
mg/dl
Creatininea
mg/dI
<55 7 193b
(—lto+52)
055b
(+0.OSto+l.34)
>8.0 7 18b
(—2 to +7)
001b
(—0.25 to +0.27)
Values are expressed as mean, with range in parentheses.
bP <0.01 for both LSUN and zcreatinine.
ULCV, pg/rn/n
N =29
r = 0.76
P <0.001
rats, or in rats injected with ovalbumin or bovine
serum albumin. Occasional casts were seen in 2 of
16 rats injected with myoglobin.
Discussion
Protein characterization. Although renal dys-
function in patients with myeloma may be due to a
wide variety of causes [7], only three manifestations
seem to bear a direct relationship to the presence of
Bence Jones proteinuria. These are (1) "myeloma
kidney," a chronic cast nephropathy with gradual
deterioration of renal function, (2) acute renal fail-
ure [7], and (3) a more rarely occurring adult Fan-
coni syndrome [29]. Possible factors that may deter-
mine Bence Jones protein nephrotoxicity include
the total load of protein excreted, structural fea-
tures determining ease of protein precipitation,
isoelectric point and charge density of the protein,
protein concentration in the tubular lumen, and
tubular fluid pH.
Although the numbers are small it is notable that
all 6 patients with A light chain had severely im-
paired renal function compared with only 1 of 5 pa-
tients with K light chain. This contrasts with the
finding of Stone and Frenkel [30] that light chain
type did not correlate with renal function in 35 pa-
tients with light chain myeloma in spite of the fact
that the proteinuric rate for A light chain has been
shown to be 2.5 times that for K [8]. It is interesting
that in the two patients with light chain myeloma
who developed acute renal failure after intravenous
urography, cast formation was not a prominent fea-
ture on renal biopsy performed at the time of onset
of the renal failure. This contrasts to most cases re-
ported of acute renal failure in patients with myelo-
40 —
30 —
20 —
10 —
0
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Fig. 2. Comparison between light change excretion rates (ULCV) and change in serum urea nitrogen concentration (AR UN) over 6 hours
following i.p. injection of300 mg of 11 different Bence Jones protein dimer preparations of p1 5.2 to 6.6 into 29 aciduric, hydropenic rats.
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ma where moderate to severe cast tormation has
been present, although it was only a minor feature
in 2 of 9 cases reported by DeFronzo et al [14].
The results of the circular dichroism studies in-
dicate that, in general, the a helical content sepa-
rates the A- from the K-type proteins. This is consis-
tent with the prediction of Kincaid and Jurgensons
[31] that A-type Bence Jones proteins contain a
greater a helical content than do the K, based on
ellipticity data near 19 nm. There is no obvious cor-
relation between either /3-pleated sheet content or
remaining secondary structure content and immu-
nologic type. With the one exception, the K-type
proteins range from 18.9 to 34.2% /3-pleated sheet,
and the A proteins range from 20.9 to 30.8%. This is
in the range predicted from X-ray [32] as well as
earlier circular dichroism data [33]. No relationship
between internal structure and nephrotoxicity was
seen in this study, though other data from our labo-
ratory show that three light chains that form crystal-
like structures in proximal tubular epithelium are all
K group I of low a-helical content [34].
In general, there was more impairment of renal
function if the Bence Jones protein isoelectric point
was high. We are not aware of any published data
that relates isoelectric point to renal function. One
previously reported case [29] describes a patient
with Fanconi syndrome, amyloidosis, and 10 year's
proteinuria with K chain of isoelectric point 6.2 who
had no evidence of impaired GFR during followup.
She did have renal tubular acidosis, however, and
serial urine pH values were never below 5.5. Thus,
her relative alkaluria may have proved a protective
mechanism. It may be that conditions of aciduria or
dehydration may have to be at least intermittantly
present for Bence Jones proteins to exert a nephro-
toxic effect.
In vivo studies. The experiments described here
were performed in the aciduric, hydropenic rat as
we postulated that these conditions would be most
likely to enhance distal cast formation. The three
control proteins were chosen for differences in fil-
terability and isoelectric point. Bovine serum albu-
min (mol wt, 66,000 daltons; p1, 4.9) is poorly fil-
tered at the glomerulus, and it is of low p1. Ov-
albumin (mol wt, 44,000 daltons; p1, 4.3) is more
readily filtered and is anionic under conditions of
aciduria. Myoglobin (mol wt, 17,000; p1, 6.8) is
readily filtered and is cationic under conditions of
aciduria. Previous experiments using a K-type
Bence Jones protein produced no deterioration Of
renal function in the same type of rat with free ac-
cess to water and urinary pH ranging from 5.8 to 7.3
[12]. The dose of protein selected here was the same
as in the previous studies. Much higher doses may
be necessary to produce a chronic cast nephropa-
thy, as shown by Koss, Pirani, and Osserman [16].
In the experiments described by these workers, in-
jection of 200 mg of a type-A Bence Jones protein
into mice was necessary to produce significant cast
formation and elevation in blood urea nitrogen un-
der conditions of free access to food and water.
Although a significant negative correlation is seen
here between Bence Jones protein isoelectric point
and urinary light chain excretion, the meaning of
this finding is uncertain, as those rats injected with
protein of higher isoelectric point had greater eleva-
tion of blood urea nitrogen and serum creatinine
over the experimental period and presumably lower
GFR. Also the failure to find a significant difference
in excretion rates for K- and A-type proteins might
be influenced by the fact that the A proteins used
here, in general, were of higher isoelectric point
than the K proteins. It is difficult to compare these
data with that of Wochner, Strober, and Waldmann
[8], who found the proteinuric rate in mice for hu-
man A light chains was approximately two and one
half that of K, as the experimental conditions were
so different with smaller doses of labeled light
chains used.
The sharp deterioration of renal function seen
here with some proteins over the 6-hour experimen-
tal period did not correlate with light chain type or
internal structure but did show a significant correla-
tion with the protein isoelectric point. The most
marked elevation of blood urea nitrogen and serum
creatinine concentrations was seen with proteins
having an isoelectric point of 5.8 or greater. As the
urinary pH was 5.5 or less, this finding suggests that
these proteins may be more nephrotoxic when cat-
ionic than when anionic or when near the isoelectric
point, where the tendency for the proteins to pre-
cipitate is greatest [35]. The mechanism of this
nephrotoxicity cannot be explained by the present
experiments. Other experiments in our laboratory
[36] have shown that Bence Jones proteins, myo-
globin, and hemoglobin coprecipitate in vitro with
Tamm Horsfall mucoprotein as pH is lowered from
6.0 to 4.5. It may be that some interaction between
the cationic Bence Jones proteins in the tubular lu-
men and the negatively charged Tamm Horsfall mu-
coprotein (p1, 3.5) which lines the distal nephron
[37] may initiate reduction of GFR in some way. It
does not seem likely that this is achieved via exten-
sive tubular obstruction because cast formation was
not that extensive in these experiments and was, in
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fact, absent in some rats with acute deterioration in
renal function. Also the failure of myoglobin (p1,
6.8) to induce acute deterioration of renal function
in this model suggests that a simple charge inter-
action is not the sole mechanism, though myo-
globinuria has long been associated with acute
nephrotoxicity, and an early paper by Bywaters and
Stead {38] described alkaluria as preventing acute
deterioration of renal function in rabbits injected
with myoglobin. Further, more precise measure-
ments of various parameters of renal function dur-
ing infusion of these proteins under conditions of
varying urinary pH would seem necessary to fur-
ther elucidate the mechanisms of this nephrotoxici-
ty.
Summary
Bence Jones proteins (BJP) were isolated from
the urine of 12 patients with multiple myeloma and
various degrees of renal dysfunction. Proteins were
characterized as to type (six type A and five type K),
isoelectric point (p1), and secondary structure by
circular dichroism (CD), Clinical renal function was
more impaired with type-A proteins and with pro-
teins of p1 > 5.7. CD studies distinguished K from A
proteins in most cases but did not correlate with
nephrotoxicity. Protein di mer preparations were
tested for nephrotoxicity in aciduric, hydropenic,
female, Sprague Dawley rats by following renal
function and morphology over 6 hours after injec-
tion i.p. of 300 mg of protein. Twelve rats of urine
pH < 5.5 injected with four BJP of p1 < 5.7 showed
a mean rise in SUN of 5.3 mg/dI and in creatinine of
0.06 mg/dl, compared with a mean rise of 28.0 mg!dl
(SUN) and 0.75 mg/dl (creatinine) in 21 rats injected
with seven BJP of p1 > 5.7 (P < 0.01). Seven so-
dium-bicarbonate-fed rats of urine pH > 8 injected
with a BJP of p1 6.2 showed mean rise in SUN of 1.8
mg/dl and in creatinine of 0.01 mgldl, compared
with 19.3 mg/dl (SUN) and 0.55 mg/dl (creatinine) in
7 aciduric rats injected with the same BJP (P =
0.009). Morphologic and immunohistologic studies
showed distal cast formation in 9 rats with acute de-
terioration in renal function. It is concluded that
BJP of p1 > urine pH are acutely nephrotoxic in the
rat by a mechanism that may involve a charge inter-
action in the distal nephron.
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